Good CARMA: Turning bad tumor‐resident myeloid cells good with chimeric antigen receptor macrophages

CM Snyder, SI Gill - Immunological Reviews, 2023 - Wiley Online Library
In religious philosophy, the concept of karma represents the effect of one's past and present
actions on one's future. Macrophages are highly plastic cells with myriad roles in health and …

Macrophage-based approaches for cancer immunotherapy

NR Anderson, NG Minutolo, S Gill, M Klichinsky - Cancer research, 2021 - AACR
Adoptive cell therapy with genetically modified T cells has generated exciting outcomes in
hematologic malignancies, but its application to solid tumors has proven challenging. This …

Cancer immunotherapies based on genetically engineered macrophages

M Cannac, J Nikolic, P Benaroch - Cancer Immunology Research, 2022 - AACR
Anticancer immunotherapies are therapeutics aimed at eliciting immune responses against
tumor cells. Immunotherapies based on adoptive transfer of engineered immune cells have …

[HTML][HTML] CARs and beyond: tailoring macrophage-based cell therapeutics to combat solid malignancies

SM Abdin, D Paasch, M Morgan… - … for Immunotherapy of …, 2021 - ncbi.nlm.nih.gov
Recent understanding of the role and contribution of immune cells in disease onset and
progression has pioneered the field of immunotherapies. Use of genetic engineering to …

Chimeric antigen receptor macrophages (CARMA) for adoptive cellular immunotherapy of solid tumors

M Klichinsky, M Ruella, O Shestova, SS Kenderian… - Cancer research, 2017 - AACR
Chimeric antigen receptor (CAR) T cell immunotherapy has demonstrated profound results
in hematologic malignancies but clinical efficacy in the solid tumor setting has not been …

[HTML][HTML] Macrophages get a CAR

MT Villanueva - Nature Reviews Cancer, 2020 - nature.com
Macrophages get a CAR | Nature Reviews Cancer Skip to main content Thank you for visiting
nature.com. You are using a browser version with limited support for CSS. To obtain the best …

[HTML][HTML] Macrophage-based combination therapies as a new strategy for cancer immunotherapy

L Tian, A Lei, T Tan, M Zhu, L Zhang, H Mou… - Kidney Diseases, 2022 - karger.com
Background: Cells of the immune system can inhibit tumor growth and progression;
however, immune cells can also promote tumor cell growth, survival, and angiogenesis as a …

[PDF][PDF] Redirecting macrophage function to sustain their “defender” antitumor activity

SL Tzetzo, SI Abrams - Cancer cell, 2021 - cell.com
Macrophages are multi-functional innate immune cells that occupy normal or pathologic
tissues, including cancer tissues. The importance of macrophage ontogeny and the …

Human chimeric antigen receptor macrophages for cancer immunotherapy

M Klichinsky, M Ruella, O Shestova, XM Lu… - Nature …, 2020 - nature.com
Chimeric antigen receptor (CAR) T cell therapy has shown promise in hematologic
malignancies, but its application to solid tumors has been challenging,,–. Given the unique …

[HTML][HTML] Engineered CAR-macrophages as adoptive immunotherapies for solid tumors

C Sloas, S Gill, M Klichinsky - Frontiers in immunology, 2021 - frontiersin.org
Cellular immunotherapies represent a promising approach for the treatment of cancer.
Engineered adoptive cell therapies redirect and augment a leukocyte's inherent ability to …